MOJA sslika

MarkPap India, LLC Bringing a new live-saving preventive cervical cancer screening in India MPI holds patents for mass pap smear screening , the best prevention measure, non-attainable for India

Cervical Cancer and MarkPap India Cancer of the cervix of the uteri, cervical cancer (CC), a major killer of women from malignant diseases is completely preventable and curable disease IF detected on time. Early detection is made by cervical cancer preventive screening. There are 300 million women at risk and only 6% (20 million living in urban areas) are protected with preventive screening. 280 million, 94% are left behind, and because of that 70,000 Indian women die per year. Mortality increases for 10% annually. MarkPap India can help. 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

HOW TO MEET DEMANDS MEASURABLE IMPACT MARKPAP INDIA HAS ADDOPTED A STRATEGY TO REVERSE NEGATIVE TRENDS OF INCREASING CERVICAL CANCER PREVALENCE AND MORTALITY IN INDIA WITH THREE TOOLS ADDRESSING TOTAL IDIAN POPULATION IN A PERIOD 10-15 YEARS AFTER NATIONAL IMPLEMENTATION OF THE STATEGY REVERSE FROM (+)10% TO (-)4% ANNUALLY 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

NEW TOOLS CONNECTING POINTS-OF-CARE WITH EXPERT CENTERS ITTHC TELEMEDICINE HOME SPECIMEN COLLECTION CANCER + HPV M-HEALTH 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

MarkPap India is already present in India At this moment, MPI is in an advanced Pre-Sale phase of Commercialization . Market research is completed, we know the local situation, customers, prices, few importers and distributors are already identified and negotiations are in progress. The formal Indian FDA approval process has been initiated. Our companies have several years long standing collaboration with All Indian Institute for Medical Research (AIIMS), where the validity of the technology has been already confirmed and joint papers published in prestigious Indian medical journals. 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

MarkPap India is already present in India, Cont. Two other Indian universities already performed independent clinical trials with favorable results. On the recent International Congress of Cytology (Paris, 2013) a joint presentation with Cytology Department at AIIMS was held entitled “Evaluation of cytology screening strategies for cervical cancer in recourse poor settings.” 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

APPLIC ATION TO TONIIC- NOV_2012 We need financial and other support from people who are Making Money-Doing Good At this moment MPI needs cash or liquid assets to finalize the pre-sale phase and to start selling. The estimated amount needed is $ 1,00,000 for two years. The cash is needed to pay for technical services such as obtaining Government approval for marketing and sale in India, operating cost of MPI, initial working capital, annual ROI, accounting/legal team cost, and return of liabilities This investment will help us bringing the pre-sale phase to the end and starting sales faster. 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

APPLIC ATION TO TONIIC- NOV_2012 MPI REVENUE MODEL CALCULATED FROM THE CHAIN OF CONTRIBUTORS FROM THE FIRST DAY OF SALES SALES: HOME KIT, REAGENT KIT, TCP SERVICE PRE-MONEY ANGELS VC/BANK INVESTMENT REVENUE PROFIT RETURN 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

APPLIC ATION TO TONIIC- NOV_2012 People Who are Making Money-Doing Good Should ALL BE DOING & FEELING WELL Besides an ENORMOUS societal impact saving tens of thousands women’s lives a HUGE financial benefit is projected. When Sale phase will start the total value including ROI will be multiplied by equivalent of ~ 10 With the beginning of sales the value of the Company will raise significantly, together with the Return on Investment. Consequently, investing into MPI at this time should be considered WIN—WIN situation, we think. 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012

APPLIC ATION TO TONIIC- NOV_2012 CONTACT Acknowledgment: We acknowledge the support of TONIIC and Ms. Alison Grant, for this opportunity For more information please visit our GUST web site: www.gust.com/c/markpap_india_llc CONTACT Prof. Dr. Olivera Markovic Senior VP and CSO MarkPap India, LLC Johns Hopkins University, Montgomery County Campus 9601 Medical Center Drive, Suite 111 Rockville, MD 20850 www.bioscicon.com E-Mail: info@bioscicon.com Tel: 301-610-9130 11/3/2012 APPLIC ATION TO TONIIC- NOV_2012